nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abnormal alternative splicing promotes tumor resistance in targeted therapy and immunotherapy
|
Deng, Kun |
|
|
14 |
6 |
p. |
artikel |
2 |
A clinical and molecular portrait of non-metastatic anal squamous cell carcinoma
|
Iseas, Soledad |
|
|
14 |
6 |
p. |
artikel |
3 |
Anti-tumor effect of carrimycin on oral squamous cell carcinoma cells in vitro and in vivo
|
Liang, Si-yuan |
|
|
14 |
6 |
p. |
artikel |
4 |
Biomarkers in renal cell carcinoma: Towards a more selective immune checkpoint inhibition
|
Sarkis, J. |
|
|
14 |
6 |
p. |
artikel |
5 |
Chemical complementarity between immune receptors and cancer mutants, independent of antigen presentation protein binding, is associated with increased survival rates
|
Hsiang, Monica |
|
|
14 |
6 |
p. |
artikel |
6 |
Chemotherapy regimens induce inhibitory immune checkpoint protein expression on stem-like and senescent-like oesophageal adenocarcinoma cells
|
Davern, Maria |
|
|
14 |
6 |
p. |
artikel |
7 |
Construction of a prognostic immune signature for lower grade glioma that can be recognized by MRI radiomics features to predict survival in LGG patients
|
Li, Zi-zhuo |
|
|
14 |
6 |
p. |
artikel |
8 |
Definition and risk factors of early recurrence based on affecting prognosis of esophageal squamous cell carcinoma patients after radical resection
|
Zhang, Yaowen |
|
|
14 |
6 |
p. |
artikel |
9 |
Distinct tumor bacterial microbiome in lung adenocarcinomas manifested as radiological subsolid nodules
|
Ma, Yi |
|
|
14 |
6 |
p. |
artikel |
10 |
Diverse and converging roles of ERK1/2 and ERK5 pathways on mesenchymal to epithelial transition in breast cancer
|
Bhatt, Akshita B. |
|
|
14 |
6 |
p. |
artikel |
11 |
Influence of cholesterol on cancer progression and therapy
|
Mayengbam, Shyamananda Singh |
|
|
14 |
6 |
p. |
artikel |
12 |
IRF2 regulates cellular survival and Lenvatinib-sensitivity of hepatocellular carcinoma (HCC) through regulating β-catenin
|
Guo, Yarong |
|
|
14 |
6 |
p. |
artikel |
13 |
MicroRNA-181a suppresses norethisterone-promoted tumorigenesis of breast epithelial MCF10A cells through the PGRMC1/EGFR–PI3K/Akt/mTOR signaling pathway
|
Cai, Guiju |
|
|
14 |
6 |
p. |
artikel |
14 |
Opinion: miRNAs – The new wave of molecular cancer therapeutics
|
Lopez-Bertoni, Hernando |
|
|
14 |
6 |
p. |
artikel |
15 |
Prediction of overall survival and response to immune checkpoint inhibitors: An immune-related signature for gastric cancer
|
Wang, Zheng |
|
|
14 |
6 |
p. |
artikel |
16 |
Remote controlling of CAR-T cells and toxicity management: Molecular switches and next generation CARs
|
Moghanloo, Ehsan |
|
|
14 |
6 |
p. |
artikel |
17 |
SMYD3 confers cisplatin chemoresistance of NSCLC cells in an ANKHD1-dependent manner
|
Lv, Hong-Wei |
|
|
14 |
6 |
p. |
artikel |
18 |
The current landscape of the FDA approved companion diagnostics
|
Jørgensen, Jan Trøst |
|
|
14 |
6 |
p. |
artikel |
19 |
The efficacy and safety of antibodies targeting PD-1 for treatment in advanced esophageal cancer: A systematic review and meta-analysis
|
Lu, Yao |
|
|
14 |
6 |
p. |
artikel |
20 |
The prognostic value of circulating tumor DNA in patients with melanoma: A systematic review and meta-analysis
|
Feng, S.N. |
|
|
14 |
6 |
p. |
artikel |
21 |
The remodelling of actin composition as a hallmark of cancer
|
Suresh, Rahul |
|
|
14 |
6 |
p. |
artikel |
22 |
Type of chemotherapy has substantial effects on the immune system in ovarian cancer
|
Vankerckhoven, Ann |
|
|
14 |
6 |
p. |
artikel |